Powder: -20°C for 3 years
In solvent: -80°C for 2 years
d[Cha4]-AVP acetate is a potent and selective human vasopressin V1B receptor agonist (Ki values are 1.2, 151, 240 and 750 nM for V1B, V1A, Oxytocin and V2 receptors respectively). Stimulates ACTH and corticosterone secretion and exhibits negligible vasopressor activity in vivo.
Description | d[Cha4]-AVP acetate is a potent and selective human vasopressin V1B receptor agonist (Ki values are 1.2, 151, 240 and 750 nM for V1B, V1A, Oxytocin and V2 receptors respectively). Stimulates ACTH and corticosterone secretion and exhibits negligible vasopressor activity in vivo. |
Molecular Weight | 1154.37 |
Formula | C52H75N13O13S2 |
CAS No. | TP2082L |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 10 mM
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
d[Cha4]-AVP acetate(500170-27-4 free base) TP2082L GPCR/G Protein Vasopressin Receptor d[Cha4]AVP acetate(500170274 free base) d[Cha4] AVP acetate(500170 27 4 free base) d[Cha-4]-AVP acetate(500170-27-4 free base) Inhibitor inhibitor inhibit